Related Experiment Video
Updated: Aug 6, 2026
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Simplification of the new Bethesda 2001 classification system
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California-Los Angeles, CA 90095-1740, USA. jberk@mednt.ucla.edu
The Bethesda System for Papanicolaou smear reporting was revised in 2001 to improve the classification of potentially premalignant squamous lesions. Updates refined categories like Atypical Squamous Cells (ASC) to better triage women for appropriate cervical cancer screening.
Area of Science:
- Cytopathology
- Gynecologic Oncology
- Cervical Cancer Screening
Background:
- The Bethesda System standardizes cytologic reporting of Papanicolaou smears.
- Previous iterations classified squamous lesions, but refinements were needed for improved diagnostic accuracy and patient management.
Purpose of the Study:
- To detail the revisions within the Bethesda III System (2001) for cytologic reporting.
- To enhance the classification of potentially premalignant squamous and glandular lesions.
- To improve the triage of women requiring further cervical cancer screening.
Main Methods:
- Review and analysis of the Bethesda III System (2001) guidelines.
- Comparison of the Bethesda III System with prior versions.
- Focus on modifications to the Atypical Squamous Cells (ASC) category and glandular cell criteria.
Main Results:
- Potentially premalignant squamous lesions are categorized into Atypical Squamous Cells (ASC), Low-Grade Squamous Intraepithelial Lesions (LGSIL), and High-Grade Squamous Intraepithelial Lesions (HGSIL).
- The ASC category is now subdivided into ASC of Unknown Significance (ASC-US) and ASC-H (cannot exclude high-grade lesion).
- Criteria for abnormal glandular epithelium, including Atypical Glandular Cells (AGC), were refined.
Conclusions:
- The revised Bethesda System (2001) enhances the classification of cervical cytologic abnormalities.
- Modifications, particularly to the ASC category, facilitate more precise patient triage for colposcopy and further screening.
- These updates aim to optimize the detection and management of cervical intraepithelial neoplasia.
More Related Videos
08:58Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
